← FDA Drug Approvals (Drugs@FDA)

TRANXENE

NDA · New Drug Application · Sponsor: AJENAT PHARMS · Approved 1972-06-23

Drug application

FDA Application #

NDA017105

Application type

New Drug Application

Brand name

TRANXENE

Generic name

Clorazepate Dipotassium

Active ingredients

CLORAZEPATE DIPOTASSIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AJENAT PHARMS

First approval

1972-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown